Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION

Approved

STANDARD

LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION

Immedica Pharma Ab🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 15, 2024
Approval ID: 151a23c96c77918b
Company: Immedica Pharma Ab
Type: Standard

Approval Details

Approval Id: 151a23c96c77918b
Drug Cima Aemps Name: LOARGYS 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION
Register Number: 1231774001
Holder Company Name: Immedica Pharma Ab
Marketing Company Name: Immedica Pharma Ab
Holder Company Detail Path: /organization/immedica-pharma-ab
Marketing Company Detail Path: /organization/immedica-pharma-ab
Authorization Date: 2024-02-15
Dosage Form: SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose: 5 mg/ml
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Immedica Pharma Ab
Company Detail Path: /organization/immedica-pharma-ab

Company Information

Pharmaceutical Company Name: Immedica Pharma Ab
Country Name: Belgium
City Name: unknown,country_be
Address: Unknown Belgian address 0
Website: http://www.immedica.com

Active Ingredients

PEGZILARGINASA

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 15, 2024

Approval ID

151a23c96c77918b

Type

Standard

Back to CIMA-AEMPS Approvals